Skip to main content
. 2019 Aug 23;17(9):493. doi: 10.3390/md17090493

Table 5.

A summary of kinase inhibitors isolated from marine algae, 2014–2019.

Compound Chemical Class Marine Source Drug Targets/Inhibitory Activity References
55 bromophenol red alga Rhodomelaceae confervoides. RTKs, p-PKB/Akt [68,69]
56 phlorotannin brown seaweed Eisenia bicyclis p-AKt [70]
57 carotenoid brown alga wakame seaweeds wakame (Undaria pinnatifida) and kombu (Laminaria japonica) AKt, MAPK [71,72,73]
58 bromophenol red alga Polysiphonia morrowii p-ERK [74]
59–60 lipopoly-saccharide brown seaweed marine alga (Eisenia bicyclis) p-ERK1/2, p-JNK [75]
61a cyclic depsipeptide marine cyanobacterium Moorea producens (formerly Lyngbya majuscula) RTKs [76]
62 a bromo-honaucin marine cyanobacterium Leptolyngbya crossbyana AKt, ERK [77,78]
63 b cyclic depsipeptide marine cyanobacterium Moorea producens JNK [79,80]
64 cyclic depsipeptide marine cyanobacterium Leptolyngbya sp. VEGFA/VEGFR2 [81,82]

a This molecule is synthetic but designed based on a marine natural product. b Hoiamide A is JNK activator.